Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:593-594 (13 March), doi:10.1136/bmj.328.7440.593
The lower the pressure the better
| The first 150 words of the full text of this article appear below. |
Hypertension represents a major public health concern. It affects about a billion people worldwide and is the most common treatable risk factor for cardiovascular disease in patients aged over 50. In the United Kingdom, the prevalence of hypertension (blood pressure more than 140/90 mm Hg) has been estimated to be 42% in people aged 35 to 64.1 Large benefits, in terms of avoided cardiovascular disease, are expected from the treatment of hypertension. However, these benefits are low because the control of hypertension remains poor in European countriesparticularly in the United Kingdom, where it is controlled in only 10% of the hypertensive population.2
These past years, a huge quantity of novel data has been published on the prominent role of lowering blood pressure in the reduction of cardiovascular disease and on the safety and effectiveness of antihypertensive drugs. Two guidelines for management of hypertension, updating previous ones, were published in 2003.3
4
Stéphane Laurent, professor and head of department
Department of Pharmacology and Inserm EMI 0107, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France (stephane.laurent@egp.ap-hop-paris.fr)
Read all Rapid Responses